This is the hover veil
Menu
Menu
Home
Living
guidelines
Clinical
flowcharts
Evidence
under review
Do you have a clinical question?
About the taskforce
About the guidelines
FAQs
News
Contact us
About the taskforce
About the guidelines
FAQs
News
Contact us
News
News
Communique
Video
Explainer
Media release
Topics
ACEM
ALEC
Allied Health Professions Australia
Antenatal corticosteroids
Anticoagulation
ANZ Guidelines
ANZICS
ANZJOG
Aprepitant
ARC
ASCOT
ASID
Australasian Sleep Association
Azithromycin
Bamlanivimab
Bamlanivimab plus etesevimab
Baricitinib
Basic Life Support
Bromhexine hydrochloride
Burnet
Cardiac arrest
CHF
Children and adolescents
CMCS
Cochrane
Colchicine
Consumer Panel
Convalescent plasma
Corticosteroids
COVID-19 COS
CPR
Delayed umbilical cord clamping
Dexamethasone
Disease-modifying treatments
Dutasteride
Enisamium
Extracorporeal membrane oxygenation
Flowchart
GPs
HCW
High-flow nasal oxygen
Hydroxychloroquine
Ian Potter Foundation
ICEG
Interferon Gamma
Interferon β-1a (inhaled)
Intravenous immunoglobulin
IPC
IPC Panel
Ivermectin
Long COVID
Monoclonal antibody therapy
N-acetylcysteine
NHMRC
NPS MedicineWise
Oestrogen containing therapies
Palliative Care
Peginterferon lambda
PIMS-TS
Podcast
Post-viral symptoms
Pregnancy and perinatal care
Pregnant & Postpartum women
Prone positioning
Prone positioning for adults (non-ventilated)
RANZCOG
RCTs
RECOVERY Trial
Regeneron
REGN-COV2
REMAP-CAP
Remdesivir
Respiratory
Respiratory management
Respiratory support
Royal Australian College of Surgeons
Sarilumab
Sofosbuvir plus daclatasvir
Telmisartan
Tocilizumab
Tociluzimab
Treatment
TSANZ
Umifenovir
Vitamin C
Vitamin D
VTE prophylaxis
Zinc
Featured
Women who lead: Sutapa Mukherjee and her journey to the Taskforce
8 March, 2021
As the female co-chair of the Taskforce Guidelines Leadership Group, the contribution of Associate Professor Sutapa Mukherjee in the fight against COVID-19 is reason enough to be recognised...
COVID-19 Research Pipeline
STUDIES
Cochrane COVID-19 Study Register
52,228
Registered/ Published
RCT
s
covid-nma.com
2,731
Registered
235
Published
SYSTEMATIC REVIEWS
Prospero
3,673
Registered
As at 1 April 2021
Tweets by evidenceCOVID19
FILTERED BY > Cochrane
Clear filter
Communique # 41
1 April, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE Convalescent plasma recommendation changed to 'do not use' The Taskforce Disease Modifying and Chemoprophylaxis Panel and the Guidelines Leadership Group have incorporated the results of the convalescent plasma arm of the RECOVERY Trial (published March 10) into the body of evidence underpinning the Taskforce's recommendation on the use of convalescent plasma in treating COVID-19. As a result,...
Communique
Communique # 40
18 March, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendation for tocilizumab in children or adolescents Further to the Taskforce's recent recommendation for the conditional use of tocilizumab for adults (25...
Communique
Communique # 39
25 February, 2021
WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE Tocilizumab upgraded to conditional recommendation The Taskforce Disease Modifying Treatment and Chemoprophylaxis Panel and the Guidelines Leadership Group have incorporated...
Communique
Communique # 38
11 February, 2021
Message from the Taskforce Chair Dear colleagues As we enter the second year of the COVID-19 pandemic it is timely to acknowledge the important role of the Taskforce’s...
Communique
Communique # 37
29 January, 2021
Following a well-earned break, the Taskforce team has now returned to full capacity. Global evidence surveillance continued throughout January, with six clinical panel meetings held since January 11....
Communique
Weekly Communique # 36
17 December, 2020
Dear colleagues, It’s hard to fully comprehend a year like 2020. The pandemic has affected us all and no doubt its impact will continue and reverberate for some...
Communique
Weekly Communique # 35
10 December, 2020
WEEK IN REVIEW Updates to the living guideline New recommendations published this week cover: Combined metabolic cofactor supplementation (CMCS) Vitamin D analogues (formerly just calcifediol, now also includes cholecalciferol) Updated...
Communique
Weekly Communique # 33
26 November, 2020
WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are...
Communique
Weekly Communique # 31
12 November, 2020
WEEK IN REVIEW IPC Panel EOI for paediatric and clinical engineering expertise The Taskforce is calling for Expressions of Interest from suitably qualified individuals with paediatric or clinical...
Communique
Weekly Communique # 30
5 November, 2020
WEEK IN REVIEW Bromhexine hydrochloride added to list of 'only in clinical trials' The Disease-Modifying Treatment and Chemoprophylaxis Panel has reviewed two new trial results for bromhexine hydrochloride (commonly...
Communique
Weekly Communique # 29
29 October, 2020
WEEK IN REVIEW Updates to the living guideline this week New recommendations Three new recommendations have been published covering: Triazavirin Other immunomodulatory agents (PIMS-TS) Aspirin and antithrombotic agents...
Communique
Weekly Communique # 28
22 October, 2020
WEEK IN REVIEW SAVING LIVES SAFELY: New CPR flowcharts published today The Taskforce, in partnership with the Infection Control Expert Group (ICEG), has published new clinical flowcharts to guide clinicians...
Communique
Weekly Communique # 27
15 October, 2020
WEEK IN REVIEW New PIMS-TS recommendations The Taskforce has made two new consensus recommendations for the management of children with suspected or confirmed Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2...
Communique
Weekly Communique # 26
8 October, 2020
With our evidence team and panels taking a much-needed break, a smaller edition today with no new recommendations or updates to the guidelines and flowcharts this week. Our next update will be next Thursday,...
Communique
